Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Entos Pharmaceuticals Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT06436911
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦Centricity Research, Toronto, Ontario, Canada
🇨🇦Diex Recherche Quebec, Québec, Quebec, Canada
A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults
Phase 1
Completed
- Conditions
- SARS-CoV-2
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Entos Pharmaceuticals Inc.
- Target Recruit Count
- 268
- Registration Number
- NCT04591184
- Locations
- 🇧🇫
National Center for Research and Training on Malaria, Ouagadougou, Burkina Faso
🇨🇦Canadian Centre for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada
🇸🇳Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF), Dakar, Senegal
News
No news found